Answers are grounded in this paper and cite their sources.
Background Serum urate testing requires venipuncture; urine dipstick testing is inexpensive and routine. Whether dipstick results add information on hyperuricemia beyond age, sex, and BMI is unknown. Objective This study aims to develop and externally validate machine learning models estimating the probability of hyperuricemia from 9 dipstick fields, age, sex, and BMI, and to quantify what the dipstick adds. Methods The development dataset included 129,535 adults with first urine tests and same-day serum urate and BMI measurements at a Korean tertiary hospital (2010-2025); 21,124 had urate levels ≥7.0 mg/dL, and 81.6% (n=105,704) had a same-day health checkup. Calibrated 12-input ensembles of Light Gradient Boosting Machine (LightGBM), Extreme Gradient Boosting (XGBoost), and Categorical Boosting (CatBoost) were trained on a person-level 80% split (103,628 persons) for serum urate ≥7.0 mg/dL (primary) and ≥9.0 mg/dL (secondary). They were tested in the remaining 25,907 persons (4225 events at ≥7.0 mg/dL) and in 49,987 adults in the KNHANES (Korea National Health and Nutrition Examination Survey; 2016-2024; 5068 events). Inputs, KNHANES coding, split, and training procedure were fixed before fitting. We assessed discrimination, calibration, operating points by sex, decision curves, and increments over age-sex-BMI models. Results At ≥7.0 mg/dL, the area under the receiver operating characteristic curve (AUROC) was 0.825 (95% CI 0.820-0.831) internally and 0.845 (95% CI 0.840-0.849) externally, but 0.710 in men and 0.795 in women. Across 4 model classes, the dipstick added 0.017 to 0.024 to the external AUROC of age-sex-BMI models (0.814-0.823), or 3.1 cases per 1000 screened with top-10% referral. Externally, the models overpredicted (observed-to-expected ratio 0.73, 95% CI 0.71-0.75); an intercept update fitted in half of KNHANES restored it to 1.00 in the other half. The internally derived 80%-sensitivity threshold flagged 29.8% (14,916/49,987) of adults, 97.4% (14,533/14,916) of them men; sensitivity was 77.1% (3907/5068) overall but 10.1% (53/527) in women, and positive predictive value (PPV) was 26.2% (3907/14,916). Flagging all men gave 89.6% (4541/5068) sensitivity and slightly less net benefit than the model at threshold probabilities up to 10%. At ≥9.0 mg/dL, external results were AUROC 0.860, increment 0.052 to 0.074 (1.6 cases per 1000), observed-to-expected ratio 0.48, scaled Brier score 0.002 (no better than predicting the prevalence), and PPV 2.6% at 82% sensitivity. Conclusions Routine dipstick results add a small increment to age, sex, and BMI for identifying serum urate ≥7.0 mg/dL. Ranking transferred from the hospital to a national survey sample, but absolute risk did not, and at the tested thresholds the models mainly selected men. Both cohorts comprised people who had blood drawn, so triage of serum urate testing in urine-only encounters, in which BMI is usually missing, remains an untested hypothesis. Before any use, the models would need local recalibration and evaluation in the intended setting.
No takes yet. Share an insight, caveat, or question.
Jang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: